Relationship between clinical efficacy and AEs of tebentafusp, a novel bispecific TCR-anti-CD3, in patients with advanced melanoma Meeting Abstract


Authors: Middleton, M. R.; Steven, N. M.; Evans, T. J.; Infante, J. R.; Sznol, M.; Hamid, O.; Shoushtari, A. N.; Anthoney, A.; Gupta, A.; Woodcock, V. K.; Abdulla, S.; Corrie, P.
Abstract Title: Relationship between clinical efficacy and AEs of tebentafusp, a novel bispecific TCR-anti-CD3, in patients with advanced melanoma
Meeting Title: Melanoma Bridge 2019
Journal Title: Journal of Translational Medicine
Volume: 18
Issue: Suppl. 1
Meeting Dates: 2019 Dec 5-7
Meeting Location: Naples, Italy
ISSN: 1479-5876
Publisher: Biomed Central Ltd  
Date Published: 2020-02-11
Start Page: 50
Language: English
ACCESSION: WOS:000514869700024
PROVIDER: wos
PMCID: PMC7011210
PUBMED: 32046729
DOI: 10.1186/s12967-020-02209-y
Notes: Meeting Abstract: 24 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors